Health Canada (HC) (30) · Innovation, Science and Economic Development Canada (ISED) (12) · House of Commons (8) · Public Health Agency of Canada (PHAC) (4) · Finance Canada (FIN) (3) · Treasury Board Of Canada Secretariat (TBS) (3)
In their own words
Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.